TransMedics Group, Inc.

TMDX 10-Q · Q1 2026

TMDX Q1 2026 request

Playground key active
Request URL /api/financials?ticker=TMDX&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 173,933 143,537 +21.2%
Show Product Lines breakouts
Heart revenue [Member] · OCS transplant revenue [Member] 25,857 26,266 -1.6%
Heart revenue [Member] · OCS transplant revenue [Member] 5,011 3,550 +41.2%
Liver revenue [Member] · OCS transplant revenue [Member] 138,970 108,715 +27.8%
Liver revenue [Member] · OCS transplant revenue [Member] 10 140 -92.9%
Lung revenue [Member] · OCS transplant revenue [Member] 2,197 3,636 -39.6%
Lung revenue [Member] · OCS transplant revenue [Member] 627 375 +67.2%
Product 107,972 88,234 +22.4%
Service 65,961 55,303 +19.3%
Service Unrelated to OCS Transplant [Member] 1.3 0.9 +44.4%
Show Business Segments breakouts
OCS transplant revenue [Member] 172,672 142,682 +21.0%
OCS transplant revenue [Member] · Non Us 5,648 4,065 +38.9%
OCS transplant revenue [Member] · US 167,024 138,617 +20.5%
Cost of Revenue 72,772 55,309 +31.6%
Show Product Lines breakouts
Product 24,308 16,312 +49.0%
Service 48,464 38,997 +24.3%
Gross Profit 101,161 88,228 +14.7%
Research & Development 24,879 17,160 +45.0%
Show Income Statement Location breakouts
Clinical trials costs 705 81 +770.4%
Consulting and third-party services 8,409 4,173 +101.5%
Facility and IT related and other 3,216 1,698 +89.4%
Laboratory supplies and research materials 4,141 4,956 -16.4%
Personnel related (including stock-based compensation expense) 8,408 6,252 +34.5%
Selling, General & Administrative 62,985 43,625 +44.4%
Show Income Statement Location breakouts
Depreciation and amortization expense 6,062 1,242 +388.1%
Facility and IT related and other 7,792 4,322 +80.3%
Headquarters relocation costs 207
NOP support 1,580 2,406 -34.3%
Personnel related (including stock-based compensation expense) 34,106 27,671 +23.3%
Professional and consultant fees 9,262 7,558 +22.5%
Tradeshows and conferences 1,269 426 +197.9%
Transaction-related costs 2,707
Operating Expenses 87,864 60,785 +44.5%
Operating Income 13,297 27,443 -51.5%
Interest Expense -7,170 -3,461 -107.2%
Interest Income And Other Income Expense 2,358 2,694 -12.5%
Non-Operating Income (Expense) -4,812 -767 -527.4%
Income Before Taxes 8,485 26,676 -68.2%
Income Tax Expense (Benefit) -1,170 -994 -17.7%
Net Income 7,315 25,682 -71.5%
Show Equity Components breakouts
Retained Earnings 7,315 25,682 -71.5%
EPS (Basic) 0.21 0.76 -72.4%
EPS (Diluted) 0.2 0.7 -71.4%
Wtd Avg Shares (Basic) 34,384,207 33,721,603 +2.0%
Wtd Avg Shares (Diluted) 36,194,023 39,914,487 -9.3%
Comprehensive Income 7,193 25,719 -72.0%
Foreign Currency Transaction Gain Loss Before Tax (Q)
Show Income Statement Location breakouts
Other Nonoperating Income Expense -0.6 0.5 -220.0%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash 461,739 310,143 +48.9%
Accounts Receivable 90,727 142,026 -36.1%
Inventory 49,890 43,380 +15.0%
Prepaid Expenses & Other Current Assets 16,924 10,369 +63.2%
Show Public Utilities Inventory breakouts
Spare Parts Inventory [Member] 4.5 4 +12.5%
Total Current Assets 619,280 505,918 +22.4%
Non-Current Assets
Property, Plant & Equipment 361,571 311,244 +16.2%
Operating Lease Right-of-Use Assets 4,858 6,007 -19.1%
Deferred Tax Assets 82,476
Restricted Cash Noncurrent 18,438 500 +3587.6%
Goodwill 11,549 11,549 0.0%
Show Business Acquisition breakouts
Summit [Member] 11.5 11.5 0.0%
Other Non-Current Assets 2,103 211 +896.7%
Total Assets 1,434,820 837,530 +71.3%
Other Assets
Finance Lease Right Of Use Asset 334,545
Current Liabilities
Accounts Payable 11,151 10,595 +5.2%
Accrued Liabilities And Other Liabilities 59,316 40,139 +47.8%
Current Portion of Long-Term Debt 15,000
Show Long-Term Debt Type breakouts
Term Loan [Member] 15,000
Deferred Revenue (Current) 2,945 2,078 +41.7%
Operating Lease Liability Current 3,508 2,791 +25.7%
Total Current Liabilities 91,920 55,603 +65.3%
Non-Current Liabilities
Convertible Debt Noncurrent 453,530 450,650 +0.6%
Other Long Term Debt Noncurrent 44,665 59,448 -24.9%
Show Long-Term Debt Type breakouts
Term Loan [Member] 44,665 59,448 -24.9%
Finance Lease Liability Noncurrent 343,829
Operating Lease Liabilities 2,883 5,521 -47.8%
Other Non-Current Liabilities 3,986
Total Liabilities 940,813 571,222 +64.7%
Stockholders' Equity
Common Stock 764,640 709,194 +7.8%
Accumulated Other Comprehensive Income 2 -327 +100.6%
Retained Earnings -270,635 -442,559 +38.8%
Total Stockholders' Equity 494,007 266,308 +85.5%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 2 -327 +100.6%
Common Stock 764,640 709,194 +7.8%
Retained Earnings -270,635 -442,559 +38.8%
Total Liabilities & Equity 1,434,820 837,530 +71.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Net Income 7,315 25,682 -71.5%
Depreciation & Amortization 11,864 6,137 +93.3%
Show Fair Value By Asset Class breakouts
Property Plant And Equipment 9.9 6.1 +62.3%
Stock-Based Compensation 9,952 8,958 +11.1%
Deferred Income Taxes 1,067
Non Cash Interest Expense 4,593 787 +483.6%
Non Cash Operating Lease Expense 610 474 +28.7%
Foreign Currency Transaction Gain Loss Unrealized 486 -573 +184.8%
Change in Accounts Receivable -6,520 -44,134 +85.2%
Change in Inventory -3,896 2,003 -294.5%
Change in Prepaid & Other Assets 1,961 1,928 +1.7%
Increase Decrease In Other Noncurrent Assets -155
Change in Accounts Payable 1,126 781 +44.2%
Increase Decrease In Accrued Liabilities And Other Operating Liabilities -3,105 -4,644 +33.1%
Change in Deferred Revenue 40 330 -87.9%
Increase Decrease In Operating Lease Liability -805 -664 -21.2%
Net Cash from Operations 24,533 -2,855 +959.3%
Investing Activities
Capital Expenditures -36,657 -27,038 -35.6%
Net Cash from Investing -36,657 -27,038 -35.6%
Inventory Transfer To Property Plant And Equipment 2,831 1,275 +122.0%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 313
Right Of Use Asset Obtained In Exchange For Finance Lease Liability 340,040
Liabilities Assumed1 3,986
Financing Activities
Proceeds From Stock Options Exercised 2,212 1,742 +27.0%
Proceeds From Stock Plans 1,688 1,286 +31.3%
Tax Withholding for Share Compensation -138
Net Cash from Financing 3,762 3,028 +24.2%
Supplemental
Unpaid Capital Expenditures 1,102 1,136 -3.0%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -327 358 -191.3%
Net Change in Cash -8,689 -26,507 +67.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 480,177 310,643 +54.6%
Restricted Cash 18,438 500 +3587.6%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key